Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors

		Phase:		Phase 1

		Treatment ID#:		1892

		Age Group:		Adults Only

		Min Karnofsky Score:		Not Specified

		Conditions:		Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed Inclusion Criteria: Previous diagnosis of GBM treated with radiotherapy with or without surgical resection and/or chemotherapy Clinical/radiographic suspicion of tumor recurrence/progression Exclusion Criteria: Previous treatment of target GBM with stereotactic radiosurgery, brachytherapy, or carmustine impregnated wafers (Gliadel).

		Last Updated:		11/19/2008

		Tumor Types:		Glioblastoma Multiforme


		Comments:		For questions or help getting into the trial, contact: Laura Knapp, Director of Clinical Trials clinicaltrial@monteris.com

		Treatment Type:		Surgery

		Contact:		Gene Barnett M.D. Professor and Chairman Brain Tumor Institute Cleveland Clinic Brain Tumor and Neuro-Oncology Center R20 9500 Euclid Ave. Cleveland, OH 44195 USA Phone: 216-445-1379 Fax: 216-444-0924 E-mail: barnett@neus.ccf.org Website: ccf.org

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By